526 related articles for article (PubMed ID: 18801417)
21. Differences between cation-chloride co-transporter functions in the visual cortex of pigmented and albino rats.
Barmashenko G; Schmidt M; Hoffmann KP
Eur J Neurosci; 2005 Mar; 21(5):1189-95. PubMed ID: 15813928
[TBL] [Abstract][Full Text] [Related]
22. Glycine receptors mediate excitation of subplate neurons in neonatal rat cerebral cortex.
Kilb W; Hanganu IL; Okabe A; Sava BA; Shimizu-Okabe C; Fukuda A; Luhmann HJ
J Neurophysiol; 2008 Aug; 100(2):698-707. PubMed ID: 18562558
[TBL] [Abstract][Full Text] [Related]
23. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro.
Drew GM; Mitchell VA; Vaughan CW
Neuropharmacology; 2005 Oct; 49(5):587-95. PubMed ID: 15921708
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of the neurokinin 3 receptor activates protein kinase C epsilon and protein kinase D in enteric neurons.
Poole DP; Amadesi S; Rozengurt E; Thacker M; Bunnett NW; Furness JB
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1245-56. PubMed ID: 18308856
[TBL] [Abstract][Full Text] [Related]
26. Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses.
Mair RD; Kauer JA
Neuropharmacology; 2007 Jan; 52(1):193-9. PubMed ID: 16895728
[TBL] [Abstract][Full Text] [Related]
27. 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons.
Mlinar B; Mascalchi S; Mannaioni G; Morini R; Corradetti R
Eur J Neurosci; 2006 Aug; 24(3):719-31. PubMed ID: 16930402
[TBL] [Abstract][Full Text] [Related]
28. Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Bert L; Rodier D; Bougault I; Allouard N; Le-Fur G; Soubrié P; Steinberg R
Synapse; 2002 Jan; 43(1):62-9. PubMed ID: 11746734
[TBL] [Abstract][Full Text] [Related]
29. Presynaptic mechanism underlying cAMP-induced synaptic potentiation in medial prefrontal cortex pyramidal neurons.
Huang CC; Hsu KS
Mol Pharmacol; 2006 Mar; 69(3):846-56. PubMed ID: 16306229
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.
Dawson LA; Cato KJ; Scott C; Watson JM; Wood MD; Foxton R; de la Flor R; Jones GA; Kew JN; Cluderay JE; Southam E; Murkitt GS; Gartlon J; Pemberton DJ; Jones DN; Davies CH; Hagan J
Neuropsychopharmacology; 2008 Jun; 33(7):1642-52. PubMed ID: 17728699
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
32. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
Steinberg R; Alonso R; Rouquier L; Desvignes C; Michaud JC; Cudennec A; Jung M; Simiand J; Griebel G; Emonds-Alt X; Le Fur G; Soubrié P
J Pharmacol Exp Ther; 2002 Dec; 303(3):1180-8. PubMed ID: 12438542
[TBL] [Abstract][Full Text] [Related]
33. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
[TBL] [Abstract][Full Text] [Related]
34. GABAergic basal forebrain neurons that express receptor for neurokinin B and send axons to the cerebral cortex.
Furuta T; Koyano K; Tomioka R; Yanagawa Y; Kaneko T
J Comp Neurol; 2004 May; 473(1):43-58. PubMed ID: 15067717
[TBL] [Abstract][Full Text] [Related]
35. Stimulus-evoked modulation of sensorimotor pyramidal neuron EPSPs.
Kohn A; Metz C; Tommerdahl MA; Whitsel BL
J Neurophysiol; 2002 Dec; 88(6):3331-47. PubMed ID: 12466450
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses.
Stacey AE; Woodhall GL; Jones RS
Eur J Neurosci; 2002 Nov; 16(10):1896-906. PubMed ID: 12453053
[TBL] [Abstract][Full Text] [Related]
37. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
[TBL] [Abstract][Full Text] [Related]
38. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus.
Liu R; Ding Y; Aghajanian GK
Neuropsychopharmacology; 2002 Sep; 27(3):329-40. PubMed ID: 12225691
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones.
Myers AC; Undem BJ
J Physiol; 1993 Oct; 470():665-79. PubMed ID: 7508508
[TBL] [Abstract][Full Text] [Related]
40. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
